| 000 | 01054 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514020353.0 | ||
| 264 | 0 | _c20020415 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1046/j.1365-2036.2001.01119.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerspaget, H W | |
| 245 | 0 | 0 |
_aInfliximab for Crohn's disease. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cDec 2001 |
||
| 300 |
_a2041-2 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aCrohn Disease _xblood |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _avan der Zon, A M | |
| 700 | 1 | _aGao, Q | |
| 700 | 1 | _avan Hogezand, R A | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 15 _gno. 12 _gp. 2041-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.2001.01119.x _zAvailable from publisher's website |
| 999 |
_c11650207 _d11650207 |
||